Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityNo recent work listed

Stefano Cereda

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5015245808. Sources: OpenAlex.

Their work

Papers
14 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2011: 4 papers · 2012: 3 papers · 2013: 6 papers · 2014: none · 2015: none · 2016: 1 paper

Papers 14

  1. (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial. Co-author DOI 10.1158/1078-0432.ccr-15-1722↗
  2. Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back. Co-author DOI 10.1002/ijc.28078↗
  3. Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma. Co-author DOI 10.1007/s13277-012-0520-2↗
  4. Neoadjuvant therapy in resectable pancreatic cancer: a critical review. First author DOI 10.1016/j.ctrv.2012.09.008↗
  5. Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial. First author DOI 10.1016/j.ejca.2013.06.041↗
  6. Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a pha… Co-author DOI 10.1016/j.ijrobp.2013.09.012↗
  7. Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced panc… Co-author DOI 10.1016/j.radonc.2013.05.011↗
  8. A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirub… First author DOI 10.1007/s00280-011-1680-2↗
  9. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Co-author DOI 10.1016/j.gie.2012.08.006↗
  10. Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. Co-author DOI 10.1245/s10434-011-2205-2↗
  11. Treatment trends in metastatic pancreatic cancer patients: Is it time to change? Co-author DOI 10.1016/j.dld.2010.09.010↗
  12. Unity is strength: one, two, or more drugs against advanced pancreatic cancer? First author DOI 10.1093/annonc/mdr008↗
  13. Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial. Co-author DOI 10.1159/000324865↗
  14. Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy. Co-author DOI 10.2217/pgs.11.109↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michele Reni · 14 shared papers, 2011–2016 · strength 0.45
  2. Carmen Belli · 5 shared papers, 2011–2016 · strength 0.19
  3. Gianpaolo Balzano · 5 shared papers, 2012–2016 · strength 0.16
  4. Paolo Passoni · 4 shared papers, 2012–2013 · strength 0.12
  5. Giuseppe Aprile · 4 shared papers, 2011–2013 · strength 0.11
  6. Andrea Mambrini · 4 shared papers, 2011–2013 · strength 0.11
  7. Eugenio Villa · 4 shared papers, 2011–2013 · strength 0.11
  8. Nadia Gisella Di Muzio · 3 shared papers, 2012–2013 · strength 0.09
  9. Michèle Milella · 3 shared papers, 2011–2013 · strength 0.09
  10. Michele Ghidini · 3 shared papers, 2011–2012 · strength 0.08
  11. Claudio Doglioni · 2 shared papers, 2012–2016 · strength 0.07
  12. Massimo Falconi · 2 shared papers, 2011–2016 · strength 0.07
  13. R. Calandrino · 2 shared papers, 2013 · strength 0.07
  14. Giovanni Mauro Cattaneo · 2 shared papers, 2013 · strength 0.07
  15. Maurizio Cantore · 2 shared papers, 2011–2013 · strength 0.06
  16. Godefridus J. Peters · 2 shared papers, 2011–2013 · strength 0.06
  17. Elisa Giovannetti · 2 shared papers, 2011–2013 · strength 0.06
  18. Enrico Vasile · 2 shared papers, 2011–2013 · strength 0.06
  19. Alessandro Passardi · 2 shared papers, 2011–2013 · strength 0.05
  20. Daniela Liberati · 1 shared paper, 2016 · strength 0.05
  21. Valentina Pasquale · 1 shared paper, 2016 · strength 0.05
  22. Erica Dugnani · 1 shared paper, 2016 · strength 0.05
  23. Lorenzo Piemonti · 1 shared paper, 2016 · strength 0.05
  24. Vito Lampasona · 1 shared paper, 2016 · strength 0.05
  25. Erica Villa · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.